Market research
FFEA.F Faes Farma, S.A
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 1B
- P/E ratio
- 16.85
- Analyst target
- Not available
- Dividend yield
- 1.9%
- Beta
- 0.34
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- ES0134950F36
- Market cap
- 1B
- P/E ratio
- 16.85
- Analyst target
- Not available
- Dividend yield
- 1.9%
- Beta
- 0.34
About
About Faes Farma, S.A
Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants services, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. The company also provides animal nutrition and health products. It offers products for various therapeutic areas. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the FFEA.F discussion.
5 years, 5 months ago
Faes Farma, S.A is currently in a long term downtrend where the price is trading 3.3% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.8.
Faes Farma, S.A's total revenue rose by 0.1% to $90M since the same quarter in the previous year.
Its net income has increased by 58.6% to $18M since the same quarter in the previous year.
Finally, its free cash flow fell by 44.6% to $5M since the same quarter in the previous year.
Based on the above factors, Faes Farma, S.A gets an overall score of 3/5.